COPENHAGEN, May 6 () - Novo Nordisk, the maker of weight-loss drug Wegovy, on Wednesday reported first-quarter revenue and adjusted operating profit above expectations and said its outlook for the year was slightly improved. The Danish drugmaker is banking on demand for its new weight-loss pill as competition with U.
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
150last 24h
876last 7d
146● bullish (7d)
96● bearish (7d)
214publishers
Reuters141d agobullish
Novo Nordisk slightly raises outlook as first-quarter profit beats forecastInvestor's Business Daily167d agobullish
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; AI-Related Stocks ReboundAmong the best stocks in earnings performance, Comfort Systems has a pristine 99 EPS Rating, the highest in IBD's air conditioning and heating products industry group.